Citadel Advisors’s DocGo DCGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-79,400
Closed -$69.7K 13186
2025
Q4
$69.7K Buy
+79,400
New +$84.8K ﹤0.01% 11867
2025
Q3
Sell
-14,600
Closed -$22.9K 12967
2025
Q2
$22.9K Sell
14,600
-42,800
-75% -$79.8K ﹤0.01% 12074
2025
Q1
$152K Buy
57,400
+14,300
+33% +$57.4K ﹤0.01% 10859
2024
Q4
$183K Buy
43,100
+40,100
+1,337% +$154K ﹤0.01% 10594
2024
Q3
$9.96K Sell
3,000
-30,200
-91% -$103K ﹤0.01% 13229
2024
Q2
$103K Sell
33,200
-29,500
-47% -$97.1K ﹤0.01% 10881
2024
Q1
$253K Buy
62,700
+61,700
+6,170% +$233K ﹤0.01% 9833
2023
Q4
$5.59K Sell
1,000
-11,300
-92% -$64.9K ﹤0.01% 13417
2023
Q3
$65.6K Buy
12,300
+9,200
+297% +$74.7K ﹤0.01% 11410
2023
Q2
$29K Buy
3,100
+600
+24% +$5.27K ﹤0.01% 12388
2023
Q1
$21.6K Buy
2,500
+1,700
+213% +$15K ﹤0.01% 13015
2022
Q4
$5.66K Sell
800
-47,700
-98% -$400K ﹤0.01% 13979
2022
Q3
$481K Buy
+48,500
New +$438K ﹤0.01% 8536
2022
Q2
Sell
-11,400
Closed -$105K 13053
2022
Q1
$105K Buy
+11,400
New +$85.8K ﹤0.01% 12241

Other funds holding DCGO

Citadel Advisors's DCGO Position: Q1 2026 in Review

Citadel Advisors held its DocGo (DCGO) position steady in Q1 2026 at 2,500,000 shares worth $1.57M. The position accounts for ﹤0.01% of the portfolio, ranked #6610.

Citadel Advisors first reported a position in DCGO in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.83M in Q3 2022. 122 funds tracked by Wall St. Rank hold DCGO as of Q1 2026.

  • Citadel Advisors held 2,500,000 shares of DocGo worth $1.57M as of Q1 2026.
  • Citadel Advisors left its DocGo share count unchanged in Q1 2026.
  • DocGo made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6610 holding.
  • Citadel Advisors first reported a position in DocGo in Q4 2021 and has held it in 18 quarters since.
  • Citadel Advisors's DocGo position peaked at $4.83M in Q3 2022.
  • 122 funds tracked by Wall St. Rank held DocGo as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.